Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
About Us
News and Events
My HPRA:
Login
Register
About Us
Our Mission, Vision and Values
What We Regulate and How We Regulate
Our Strategic Plan 2021 – 2025
Contact Us
Our Structure
Patient Forum
Publications & Forms
Standards of Service
Privacy and Data Protection
Information and transparency
Consultations
Quality Management
Recruitment
Report an Issue
Legislation
Extranets
News and Events
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Summary of Direct Healthcare Professional Communications (DHPCs) issued in January 2019
News Category:
3rd party
Date:
04/02/2019
Please find below the links to all Direct Healthcare Professional Communications (DHPCs) issued in January 2019
18.01.2019
Medicinal products containing carbimazole or thiamazole - Important Safety Info from Amdipharm Limited and Essential-Healthcare Ltd as approved by the HPRA
22.01.2019
Sodium-Glucose-Co-Transporter 2 inhibitors (SGLT2i) - Important Safety Information from marketing authorisation holders of products containing SGLT2 inhibitors as approved by the HPRA
31.01.2019
Lartruvo (olaratumab) - Important Safety Information from Eli Lilly & Company as approved by the HPRA
« Back
Date Printed: 29/03/2024